Wednesday, March 15, 2017 5:17:15 PM
A couple of slides from their recent event.
It took other new insulin products a few years to get traction. So you have to expect that Afrezza will be the same.
Patience to get patients.
MannKind Highlights
Afrezza - Preferred patient experience
Listen to this podcast with Mike Castagna from MannKind
Afrezza usage podcast
Want to find out about Afrezza?
Click Snap Inhale
Text Afrezza to 99000
Nothing is every guaranteed but this Chinese fortune cookie might have it right.
Recent MNKD News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
